United States Cyclophosphamide Market Report 2018

March 2018 | 109 pages | ID: U3631214DB7QEN
QYResearch

Abstracts

In this report, the United States Cyclophosphamide market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Cyclophosphamide in these regions, from 2013 to 2025 (forecast).

United States Cyclophosphamide market competition by top manufacturers/players, with Cyclophosphamide sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Baxter
• Roxane
• GLS Pharma Ltd
• Sanofi
• CSC PHARMACEUTICALS INTERNATIONAL
• LGM Pharma
• Pfizer
• Merck
• Allergan
• The Medicines Company
• Theravance Biopharma
• Basilea Pharmaceutica

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Cyclophosphamide Powder
• Cyclophosphamide Injection

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Cancer
• Autoimmune Diseases
• AL Amyloidosis
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Cyclophosphamide Market Report 2018

1 CYCLOPHOSPHAMIDE OVERVIEW

1.1 Product Overview and Scope of Cyclophosphamide
1.2 Classification of Cyclophosphamide by Product Category
  1.2.1 United States Cyclophosphamide Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Cyclophosphamide Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Cyclophosphamide Powder
  1.2.4 Cyclophosphamide Injection
1.3 United States Cyclophosphamide Market by Application/End Users
  1.3.1 United States Cyclophosphamide Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Cancer
  1.3.3 Autoimmune Diseases
  1.3.4 AL Amyloidosis
  1.3.5 Other
1.4 United States Cyclophosphamide Market by Region
  1.4.1 United States Cyclophosphamide Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Cyclophosphamide Status and Prospect (2013-2025)
  1.4.3 Southwest Cyclophosphamide Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Cyclophosphamide Status and Prospect (2013-2025)
  1.4.5 New England Cyclophosphamide Status and Prospect (2013-2025)
  1.4.6 The South Cyclophosphamide Status and Prospect (2013-2025)
  1.4.7 The Midwest Cyclophosphamide Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Cyclophosphamide (2013-2025)
  1.5.1 United States Cyclophosphamide Sales and Growth Rate (2013-2025)
  1.5.2 United States Cyclophosphamide Revenue and Growth Rate (2013-2025)

2 UNITED STATES CYCLOPHOSPHAMIDE MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Cyclophosphamide Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Cyclophosphamide Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Cyclophosphamide Average Price by Players/Suppliers (2013-2018)
2.4 United States Cyclophosphamide Market Competitive Situation and Trends
  2.4.1 United States Cyclophosphamide Market Concentration Rate
  2.4.2 United States Cyclophosphamide Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Cyclophosphamide Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES CYCLOPHOSPHAMIDE SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Cyclophosphamide Sales and Market Share by Region (2013-2018)
3.2 United States Cyclophosphamide Revenue and Market Share by Region (2013-2018)
3.3 United States Cyclophosphamide Price by Region (2013-2018)

4 UNITED STATES CYCLOPHOSPHAMIDE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Cyclophosphamide Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Cyclophosphamide Revenue and Market Share by Type (2013-2018)
4.3 United States Cyclophosphamide Price by Type (2013-2018)
4.4 United States Cyclophosphamide Sales Growth Rate by Type (2013-2018)

5 UNITED STATES CYCLOPHOSPHAMIDE SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Cyclophosphamide Sales and Market Share by Application (2013-2018)
5.2 United States Cyclophosphamide Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES CYCLOPHOSPHAMIDE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Baxter
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Cyclophosphamide Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Baxter Cyclophosphamide Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Roxane
  6.2.2 Cyclophosphamide Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Roxane Cyclophosphamide Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 GLS Pharma Ltd
  6.3.2 Cyclophosphamide Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 GLS Pharma Ltd Cyclophosphamide Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Sanofi
  6.4.2 Cyclophosphamide Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Sanofi Cyclophosphamide Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 CSC PHARMACEUTICALS INTERNATIONAL
  6.5.2 Cyclophosphamide Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 CSC PHARMACEUTICALS INTERNATIONAL Cyclophosphamide Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 LGM Pharma
  6.6.2 Cyclophosphamide Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 LGM Pharma Cyclophosphamide Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Pfizer
  6.7.2 Cyclophosphamide Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Pfizer Cyclophosphamide Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Merck
  6.8.2 Cyclophosphamide Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Merck Cyclophosphamide Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Allergan
  6.9.2 Cyclophosphamide Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Allergan Cyclophosphamide Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 The Medicines Company
  6.10.2 Cyclophosphamide Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 The Medicines Company Cyclophosphamide Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 Theravance Biopharma
6.12 Basilea Pharmaceutica

7 CYCLOPHOSPHAMIDE MANUFACTURING COST ANALYSIS

7.1 Cyclophosphamide Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Cyclophosphamide

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Cyclophosphamide Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Cyclophosphamide Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES CYCLOPHOSPHAMIDE MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Cyclophosphamide Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Cyclophosphamide Sales Volume Forecast by Type (2018-2025)
11.3 United States Cyclophosphamide Sales Volume Forecast by Application (2018-2025)
11.4 United States Cyclophosphamide Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Cyclophosphamide
Figure United States Cyclophosphamide Market Size (K MT) by Type (2013-2025)
Figure United States Cyclophosphamide Sales Volume Market Share by Type (Product Category) in 2017
Figure Cyclophosphamide Powder Product Picture
Figure Cyclophosphamide Injection Product Picture
Figure United States Cyclophosphamide Market Size (K MT) by Application (2013-2025)
Figure United States Sales Market Share of Cyclophosphamide by Application in 2017
Figure Cancer Examples
Table Key Downstream Customer in Cancer
Figure Autoimmune Diseases Examples
Table Key Downstream Customer in Autoimmune Diseases
Figure AL Amyloidosis Examples
Table Key Downstream Customer in AL Amyloidosis
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Cyclophosphamide Market Size (Million USD) by Region (2013-2025)
Figure The West Cyclophosphamide Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Cyclophosphamide Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Cyclophosphamide Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Cyclophosphamide Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Cyclophosphamide Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Cyclophosphamide Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Cyclophosphamide Sales (K MT) and Growth Rate (2013-2025)
Figure United States Cyclophosphamide Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Cyclophosphamide Market Major Players Product Sales Volume (K MT) (2013-2018)
Table United States Cyclophosphamide Sales (K MT) of Key Players/Suppliers (2013-2018)
Table United States Cyclophosphamide Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Cyclophosphamide Sales Share by Players/Suppliers
Figure 2017 United States Cyclophosphamide Sales Share by Players/Suppliers
Figure United States Cyclophosphamide Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Cyclophosphamide Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Cyclophosphamide Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Cyclophosphamide Revenue Share by Players/Suppliers
Figure 2017 United States Cyclophosphamide Revenue Share by Players/Suppliers
Table United States Market Cyclophosphamide Average Price (USD/MT) of Key Players/Suppliers (2013-2018)
Figure United States Market Cyclophosphamide Average Price (USD/MT) of Key Players/Suppliers in 2017
Figure United States Cyclophosphamide Market Share of Top 3 Players/Suppliers
Figure United States Cyclophosphamide Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Cyclophosphamide Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Cyclophosphamide Product Category
Table United States Cyclophosphamide Sales (K MT) by Region (2013-2018)
Table United States Cyclophosphamide Sales Share by Region (2013-2018)
Figure United States Cyclophosphamide Sales Share by Region (2013-2018)
Figure United States Cyclophosphamide Sales Market Share by Region in 2017
Table United States Cyclophosphamide Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Cyclophosphamide Revenue Share by Region (2013-2018)
Figure United States Cyclophosphamide Revenue Market Share by Region (2013-2018)
Figure United States Cyclophosphamide Revenue Market Share by Region in 2017
Table United States Cyclophosphamide Price (USD/MT) by Region (2013-2018)
Table United States Cyclophosphamide Sales (K MT) by Type (2013-2018)
Table United States Cyclophosphamide Sales Share by Type (2013-2018)
Figure United States Cyclophosphamide Sales Share by Type (2013-2018)
Figure United States Cyclophosphamide Sales Market Share by Type in 2017
Table United States Cyclophosphamide Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Cyclophosphamide Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Cyclophosphamide by Type (2013-2018)
Figure Revenue Market Share of Cyclophosphamide by Type in 2017
Table United States Cyclophosphamide Price (USD/MT) by Types (2013-2018)
Figure United States Cyclophosphamide Sales Growth Rate by Type (2013-2018)
Table United States Cyclophosphamide Sales (K MT) by Application (2013-2018)
Table United States Cyclophosphamide Sales Market Share by Application (2013-2018)
Figure United States Cyclophosphamide Sales Market Share by Application (2013-2018)
Figure United States Cyclophosphamide Sales Market Share by Application in 2017
Table United States Cyclophosphamide Sales Growth Rate by Application (2013-2018)
Figure United States Cyclophosphamide Sales Growth Rate by Application (2013-2018)
Table Baxter Basic Information List
Table Baxter Cyclophosphamide Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Baxter Cyclophosphamide Sales Growth Rate (2013-2018)
Figure Baxter Cyclophosphamide Sales Market Share in United States (2013-2018)
Figure Baxter Cyclophosphamide Revenue Market Share in United States (2013-2018)
Table Roxane Basic Information List
Table Roxane Cyclophosphamide Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Roxane Cyclophosphamide Sales Growth Rate (2013-2018)
Figure Roxane Cyclophosphamide Sales Market Share in United States (2013-2018)
Figure Roxane Cyclophosphamide Revenue Market Share in United States (2013-2018)
Table GLS Pharma Ltd Basic Information List
Table GLS Pharma Ltd Cyclophosphamide Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure GLS Pharma Ltd Cyclophosphamide Sales Growth Rate (2013-2018)
Figure GLS Pharma Ltd Cyclophosphamide Sales Market Share in United States (2013-2018)
Figure GLS Pharma Ltd Cyclophosphamide Revenue Market Share in United States (2013-2018)
Table Sanofi Basic Information List
Table Sanofi Cyclophosphamide Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Sanofi Cyclophosphamide Sales Growth Rate (2013-2018)
Figure Sanofi Cyclophosphamide Sales Market Share in United States (2013-2018)
Figure Sanofi Cyclophosphamide Revenue Market Share in United States (2013-2018)
Table CSC PHARMACEUTICALS INTERNATIONAL Basic Information List
Table CSC PHARMACEUTICALS INTERNATIONAL Cyclophosphamide Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure CSC PHARMACEUTICALS INTERNATIONAL Cyclophosphamide Sales Growth Rate (2013-2018)
Figure CSC PHARMACEUTICALS INTERNATIONAL Cyclophosphamide Sales Market Share in United States (2013-2018)
Figure CSC PHARMACEUTICALS INTERNATIONAL Cyclophosphamide Revenue Market Share in United States (2013-2018)
Table LGM Pharma Basic Information List
Table LGM Pharma Cyclophosphamide Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure LGM Pharma Cyclophosphamide Sales Growth Rate (2013-2018)
Figure LGM Pharma Cyclophosphamide Sales Market Share in United States (2013-2018)
Figure LGM Pharma Cyclophosphamide Revenue Market Share in United States (2013-2018)
Table Pfizer Basic Information List
Table Pfizer Cyclophosphamide Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Pfizer Cyclophosphamide Sales Growth Rate (2013-2018)
Figure Pfizer Cyclophosphamide Sales Market Share in United States (2013-2018)
Figure Pfizer Cyclophosphamide Revenue Market Share in United States (2013-2018)
Table Merck Basic Information List
Table Merck Cyclophosphamide Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Merck Cyclophosphamide Sales Growth Rate (2013-2018)
Figure Merck Cyclophosphamide Sales Market Share in United States (2013-2018)
Figure Merck Cyclophosphamide Revenue Market Share in United States (2013-2018)
Table Allergan Basic Information List
Table Allergan Cyclophosphamide Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Allergan Cyclophosphamide Sales Growth Rate (2013-2018)
Figure Allergan Cyclophosphamide Sales Market Share in United States (2013-2018)
Figure Allergan Cyclophosphamide Revenue Market Share in United States (2013-2018)
Table The Medicines Company Basic Information List
Table The Medicines Company Cyclophosphamide Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure The Medicines Company Cyclophosphamide Sales Growth Rate (2013-2018)
Figure The Medicines Company Cyclophosphamide Sales Market Share in United States (2013-2018)
Figure The Medicines Company Cyclophosphamide Revenue Market Share in United States (2013-2018)
Table Theravance Biopharma Basic Information List
Table Basilea Pharmaceutica Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cyclophosphamide
Figure Manufacturing Process Analysis of Cyclophosphamide
Figure Cyclophosphamide Industrial Chain Analysis
Table Raw Materials Sources of Cyclophosphamide Major Players/Suppliers in 2017
Table Major Buyers of Cyclophosphamide
Table Distributors/Traders List
Figure United States Cyclophosphamide Sales Volume (K MT) and Growth Rate Forecast (2018-2025)
Figure United States Cyclophosphamide Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Cyclophosphamide Price (USD/MT) Trend Forecast (2018-2025)
Table United States Cyclophosphamide Sales Volume (K MT) Forecast by Type (2018-2025)
Figure United States Cyclophosphamide Sales Volume (K MT) Forecast by Type (2018-2025)
Figure United States Cyclophosphamide Sales Volume (K MT) Forecast by Type in 2025
Table United States Cyclophosphamide Sales Volume (K MT) Forecast by Application (2018-2025)
Figure United States Cyclophosphamide Sales Volume (K MT) Forecast by Application (2018-2025)
Figure United States Cyclophosphamide Sales Volume (K MT) Forecast by Application in 2025
Table United States Cyclophosphamide Sales Volume (K MT) Forecast by Region (2018-2025)
Table United States Cyclophosphamide Sales Volume Share Forecast by Region (2018-2025)
Figure United States Cyclophosphamide Sales Volume Share Forecast by Region (2018-2025)
Figure United States Cyclophosphamide Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources